Philip C Prorok

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Cancer screening trials: nuts and bolts
    Philip C Prorok
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Semin Oncol 37:216-23. 2010
  2. ncbi Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design
    Stuart G Baker
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7354, USA
    BMC Med Res Methodol 4:12. 2004
  3. ncbi Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening
    Stuart G Baker
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, USA
    BMC Med Res Methodol 3:4. 2003
  4. ncbi Statistical issues in randomized trials of cancer screening
    Stuart G Baker
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA
    BMC Med Res Methodol 2:11. 2002

Collaborators

Detail Information

Publications4

  1. ncbi Cancer screening trials: nuts and bolts
    Philip C Prorok
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Semin Oncol 37:216-23. 2010
    ..Throughout the presentation we illustrate topics with examples from completed or ongoing RCTs, including the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and the National Lung Screening Trial (NLST)...
  2. ncbi Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design
    Stuart G Baker
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7354, USA
    BMC Med Res Methodol 4:12. 2004
    ..The original formulation involved short-term outcomes; the challenge here is accommodating long-term outcomes...
  3. ncbi Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening
    Stuart G Baker
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, USA
    BMC Med Res Methodol 3:4. 2003
    ....
  4. ncbi Statistical issues in randomized trials of cancer screening
    Stuart G Baker
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA
    BMC Med Res Methodol 2:11. 2002
    ..Although some of these issues have been discussed previously, we present important recent and new methodologies...